MYC and cancer: EPIC1 has been found to promote the cell resistance to iBET762 (bromodomain and extra-terminal motif inhibitor) and JQ-1 via activation of MYC transcriptional activity in cancer cells,26 suggesting that EPIC1 could be useful as a predictive lncRNA for BET inhibitors.